Liver Specialists of Texas Articles RSS Feed

Dr. Galati Discusses Fruits and Vegetables

Joseph Galati, M.D. - noemail@texasliver.com — Sun, 29 Jan 2012 18:00:00 GMT

In this video blog, Dr. Joe Galati discusses frozen fruits and vegetables, and how to make the best selection at the food store.

View the You Tube Video here.

29-Jan-12 12:00 PM

Psychiatric Side Effects of Hepatitis C Therapy: Parts 1 and 2

Joseph Galati, M.D. - noemail@texasliver.com — Fri, 11 Nov 2011 14:00:00 GMT

Our latest video, as part of the Hepatitis C Education Program, is a two-part video featuring Dr. Jennifer Pate, a psychiatrist specializing in the care of patients with chronic liver disease.

The video blog can be viewed here for more details.

11-Nov-11 8:00 AM

Hepatitis C Treatment: Side Effects Management with Dr. Saira Khaderi

Joseph Galati, M.D. - noemail@texasliver.com — Sun, 02 Oct 2011 04:00:00 GMT

In this You Tube video, Dr. Khaderi discussed several of the commonly encountered side effects related to hepatitis C therapy with interferon, ribavirin, and the new protease inhibitors.

To view the video on our You Tube Channel, click here.

1-Oct-11 11:00 PM

Liver Specialists of Texas Newsletter 21-Sep-11

Joseph Galati, M.D. - noemail@texasliver.com — Thu, 22 Sep 2011 13:03:30 GMT

Welcome to the Liver Specialists of Texas newsletter of upcoming events, articles, and more from our membership. We all appreciate your interest in our practice, and learning more about liver disease, new treatments that are available, health and wellness, and the prevention of disease.

Here is the latest from Liver Specialists of Texas.

Colon Cancer Video: Colon cancer is the number three cancer that adults are at risk for. We recently posted a video that is a perfect example of a patient who neglected rectal bleeding, only to find out there was a large polyp looming in his colon. To view the video, click here.

New Hepatitis C Research Opportunities: We continue to participate in clinical research studies for hepatitis C that are available for those either naive to HCV therapy (never treated) or those that have experience with therapy and never fully cleared the virus. One of the new studies is specificially researching African American and Latino adults with hepatitis C. If interested, you can contact our office for details. To learn more, click here.

Inside Look at Liver Transplant Surgery: View photographs of a liver transplant performed a couple of years ago, performed by Dr. Mark Ghobrial, and photographed by Dr. Galati. To view the video, click here.

New FDA Approved HCV Therapy-What You Need to Know, A Podcast: Listen to Dr. Galati discuss the new hepatitis C therapies recently FDA approved. Listed here.

Dietary Fiber: By request, one of the most popular downloads, this article reviewed a plan to increase your dietary fiber. With planning, you can increase your daily fiber to 30-40 grams. Start increasing your fiber by clicking here.

Tune in to Your Health First: Every Sunday evening at 7:00 p.m., tune into Your Health First, Dr. Galati's weekly radio program that discusses current health and wellness topics, with experts from around the world. Listen live at 740 KTRH or on the web at www.ktrh.com.

Staff Profile-Saira Khaderi, M.D.: Dr. Saira Khaderi has been with Liver Specialists of Texas for 1 year, and her presence has enhanced the patient experience greatly. Dr. Khaderi this year will be developing a specialized clinic for those individuals with non-alcoholic fatty liver disease. Deatails on this will follow in the next few months.

Stay up to date with our RSS feeds.

22-Sep-11 8:03 AM

Dr. Saira Khaderi Discussed Liver Disease

Joseph Galati, M.D. - noemail@texasliver.com — Tue, 17 May 2011 00:00:00 GMT

16-May-11 7:00 PM

Liver Specialists of Texas Newsletter 14-May-11

Joseph Galati, M.D. - noemail@texasliver.com — Sun, 15 May 2011 03:58:05 GMT

Welcome to the Liver Specialists of Texas newsletter of upcoming events, articles, jobs and more from our membership.

Yesterday, the FDA give approval to Boceprevir, the first in-class direct acting agent against hepatitis C. This is a long awaited announcement, and great news for patients and providers caring for hepatitis C. A You Tube video is available for review, with Dr. Galati's discussion of how patients will be evaluated and considered for treatment with Boceprevir.

Boceprevir Receives FDA Approval: A You Tube Video

A You Tube video of the announcement by Dr. Joe Galati is posted, discussing how Liver Specialists of Texas will evaluate and treat both new and old patients with Boceprevir. After years of research, and great anticipation by patients and physicians involved in the care of patients with hepatitis C, Boceprevier was finially approved yesterday. Yesterday was a very important day for those of us involved in the care of patients with hepatitis C, as well as the millions of... [More Info]

Conatus Continues New HCV Drug Development

A new financial report by Conatus, a company who is involved with HCV drug development, reports continued investment in their new HCV drugs. We are fortunate that we are conducting studies with their new agents, with good results. For more information, read the blog entry here.

New Hepatitis C Drug, Boceprevir, Features in New England Journal

Dr. Galati posted a blog entry from Berlin where he is attending the European Association for the Study of Liver Disease. Read the entire blog here.

Liver Specialists of Texas Supports The First Colony Dream League

Dr. Galati and Liver Specialists of Texas are 2011 supporters of the First Colony Dream League. First Colony Dream League is a Little League program in Sugar Land, Texas. The Dream League is a division of First Colony Little League (FCLL) and was established in Spring 2007. The Dream League roster is approximately 60 physically- and/or mentally- challenged players. In addition, the league has an Angels in the Outfield program, where approximately 150 teenage boys and girls from Ft.... [More Info]

OraSure Technologies Rapid Hepatitis C Test

OraSure Technologies Rapid Hepatitis C Test has been submitted to the FDA for a CLIA waiver, which would allow greater availability to this screening hepatitis C test for those at risk for hepatitis C. Read Dr. Galati's blog entry for more details.

The Five Most Common Questions Liver Transplant Patients Ask Dr. Galati

Dr. Galati recently narrated this You Tube video on The Five Most Common Questions Liver Transplant Patients Ask. If you have additional questions, contact us.

Telaprevir and Boceprevir: FDA Approval Soon

There is great excitement regarding the soon to be FDA approval of both Telaprevir and Boceprevir, in the treatment of chronic heaptitis C. Read here for more information on Dr. Galati's opinion on what will be coming later this summer.

Stay up to date with our RSS feeds.

14-May-11 10:58 PM

Boceprevir Receives FDA Approval: A You Tube Video

Dr. Joseph Galati Galati - noemail@texasliver.com — Sun, 15 May 2011 01:30:00 GMT

A You Tube video of the announcement by Dr. Joe Galati is posted, discussing how Liver Specialists of Texas will evaluate and treat both new and old patients with Boceprevir.

After years of research, and great anticipation by patients and physicians involved in the care of patients with hepatitis C, Boceprevier was finially approved yesterday.

Yesterday was a very important day for those of us involved in the care of patients with hepatitis C, as well as the millions of individuals affected by it. I received word yesterday afternoon that the FDA has approved boceprevir for the treatment of G1 CHC in previously untreated patients and patients who have failed previous interferon and ribavirin therapy. Boceprevir is the first in class direct acting antiviral to be FDA approved for CHC. Manufactured by Merck pharmaceutical company, the new drug will be commercially available by the name VICTRELIS.

It is expected that VICTRELIS will be available in your local pharmacy very soon.

Keep in mind these new protease inhibitors are given in combination with interferon and ribavirin.

For the first time in nearly 10 years, we have a new drug to treat and cure those with hepatitis C. The clinical research leading up to its approval is stunning, with the highest success rates ever seen in hepatitis C. This is truly a landmark breakthrough in medicine. For those waiting for “the new drugs to treat hepatitis C”, you day has come.

For those patients of ours at Liver Specialists of Texas, I anticipate to be hearing from all of you very soon. It will take time to get all of you scheduled and seen by our hepatitis C treatment team. Call our office to get the ball rolling, and in the meantime, I’d ask that you do the following:

Make sure you have all of your old records related to past hepatitis C treatments. It is important to see how you responded previously, and what special attention you may need as we re-treat you.
If you have had a prior liver biopsy, an outside facility, do your best to get a copy of the report.
When you call the office, we need to know if you have been treated in the past, or naïve (never treated) for hepatitis C.
If you have been treated, we’d like to know your past response to therapy.
Were you a null responder, non-responder, or a responder relapser. Again, this will help tailor how you will be treated.
When speaking with our staff, let us know if you have diabetes, heart disease, kidney disease, or received a prior liver or kidney transplant. The more information we have about you, the better we can care for you.

In the next few days, we will have posted on the web a hepatitis C questionnaire, dealing with some of these issues just mentioned. All of are looking forward to an orderly evaluation process for our patients.

If you are going to be new to our practice, additional intake information will be needed and forwarded to you.

All of us at Liver Specialists of Texas are very happy with these developments, and we look forward to caring for you.

Visit our website often as new information will be posted daily.

14-May-11 8:30 PM

Conatus Continues New HCV Drug Development

Dr. Joseph Galati - noemail@texasliver.com — Thu, 14 Apr 2011 17:00:00 GMT

For more information, read the blog entry here.

14-Apr-11 12:00 PM

New Hepatitis C Drug, Boceprevir, Features in New England Journal

Dr. Joseph Galati Galati - noemail@texasliver.com — Thu, 31 Mar 2011 23:00:00 GMT

Dr. Galati posted a blog entry from Berlin where he is attending the European Association for the Study of Liver Disease. Read the entire blog here.

31-Mar-11 6:00 PM

Liver Specialists of Texas Supports The First Colony Dream League

Dr. Joseph Galati Galati - noemail@texasliver.com — Sun, 27 Mar 2011 19:00:00 GMT

Dr. Galati and Liver Specialists of Texas are 2011 supporters of the First Colony Dream League.

First Colony Dream League is a Little League program in Sugar Land, Texas. The Dream League is a division of First Colony Little League (FCLL) and was established in Spring 2007. The Dream League roster is approximately 60 physically- and/or mentally- challenged players. In addition, the league has an "Angels in the Outfield" program, where approximately 150 teenage boys and girls from Ft. Bend area schools volunteer to assist Dream League players during the game, becoming a loyal buddy in the process.

View the opening day video here.

27-Mar-11 2:00 PM

OraSure Technologies Rapid Hepatitis C Test

Dr. Joseph Galati Galati - noemail@texasliver.com — Thu, 24 Mar 2011 23:00:00 GMT

Read Dr. Galati's blog entry for more details.

24-Mar-11 6:00 PM

The Five Most Common Questions Liver Transplant Patients Ask Dr. Galati

Joseph Galati, M.D. - noemail@texasliver.com — Wed, 16 Mar 2011 02:00:00 GMT

Dr. Galati recently narrated this You Tube video on The Five Most Common Questions Liver Transplant Patients Ask.

If you have additional questions, contact us.

15-Mar-11 9:00 PM

Telaprevir and Boceprevir: FDA Approval Soon

Dr. Joseph Galati Galati - noemail@texasliver.com — Tue, 01 Mar 2011 01:00:00 GMT

There is great excitement regarding the soon to be FDA approval of both Telaprevir and Boceprevir, in the treatment of chronic heaptitis C.

Read here for more information on Dr. Galati's opinion on what will be coming later this summer.

28-Feb-11 7:00 PM

Liver Specialists of Texas Newsletter 14-Jan-11

Dr. Joseph Galati Galati - noemail@texasliver.com — Fri, 14 Jan 2011 22:11:06 GMT

Welcome to the Liver Specialists of Texas newsletter of upcoming events, articles, jobs and more from our membership.

Access To Your Medical Records SoonTo Be Available

In the next several days, acces to your medical records will be available for those that are patients of our practice at Liver Specialists of Texas. Through eMDs, the electronic medical record that we use, a patient portal will be established. Before logging into the portal, you must first be issues a login and password. This can be done by first filling out this electronic release... [More Info]

Don't Eat At Olive Garden

Dr. Joe Galati spoke about an experience at an Olive Garden Resturant recently on his radio program Your Health First several months ago.

Colon Cancer Interview With Dr. Joe Galati

This is an archived radio interview and podcast Dr. Galati performed a few years ago during an episode of Your Health First, his weekly radio program on Clear Channel's 740 KTRH. He was discussing colon cancer with two patients who have an interesting story to tell regarding colon cancer. The podcast can be listed to by going to the podcast page, where you will see all of the podcast episodes.

Visit the Liver Specialists of Texas blog here

Stay up to date with our RSS feeds.

14-Jan-11 4:11 PM

Access To Your Medical Records SoonTo Be Available

Dr. Joseph Galati Galati - noemail@texasliver.com — Mon, 10 Jan 2011 20:00:00 GMT

Before logging into the portal, you must first be issues a login and password. This can be done by first filling out this electronic release form that our office must process. It only takes a few minutes, but is the first step to accessing your files. The release form can be downloaded here.

The Patient Portal is a web-based system that serves as a secure communication link between you and the clinic. When you log in to the Portal with your private user name and password, you can see information that is pulled from your electronic record at the clinic and displayed on the web page.

After logging in to Portal, you can:

•Use the messaging feature to communicate with clinic staff.

•View your health summary information.

•Send health summary information update requests if you notice missing information.

•View results of lab and other diagnostic tests.

•Schedule, confirm, cancel, or reschedule an appointment.

•Add an appointment request to your wait list.

•Request a referral or a medication refill.

Print or save an electronic copy of your Health Summary using the standard Continuity of Care Record (CCR) format.

To access the patient portal, you start by heading to our practice website. On the homepage, there is a new login link that will take you to the patient portal entry.

Instructions posted below with the attached PDF file can guide you through the login process.

Prior to obtaining permission, you will need to receive a secure password that allows you entry into the system.

10-Jan-11 2:00 PM

Don't Eat At Olive Garden

Dr. Joseph Galati Galati - noemail@texasliver.com — Wed, 05 Jan 2011 23:00:00 GMT

Dr. Joe Galati spoke about an experience at an Olive Garden Resturant recently on his radio program Your Health First several months ago.

5-Jan-11 5:00 PM

Colon Cancer Interview With Dr. Joe Galati

Dr. Joseph Galati Galati - noemail@texasliver.com — Tue, 04 Jan 2011 21:00:00 GMT

This is an archived radio interview and podcast Dr. Galati performed a few years ago during an episode of "Your Health First", his weekly radio program on Clear Channel's 740 KTRH. He was discussing colon cancer with two patients who have an interesting story to tell regarding colon cancer.

The podcast can be listed to by going to the podcast page, where you will see all of the podcast episodes.

4-Jan-11 3:00 PM

Liver Specialists of Texas Newsletter 24-Dec-10

Dr. Joseph Galati Galati - noemail@texasliver.com — Fri, 24 Dec 2010 16:00:00 GMT

Welcome to the Liver Specialists of Texas newsletter of upcoming events, articles, and more from our membership.

December 2010

Dear Friends, Colleagues, and Patients of Liver Specialists of Texas:

I hope this message finds each and every one of you in good health, as we celebrate Christmas and the Holiday Season, with optimistic hopes for the New Year.

2010 has been an exciting year for our staff and patients. Earlier this fall, we had the addition of Dr. Saira Khaderi to our practice, a well trained and knowledgeable physician, committed to the care of our patients with liver disease. We also had the opportunity to enroll a large number of patients in various hepatitis C research studies, providing them the highest chances of eradicating this dreadful infection. For those with more advanced complications of liver disease, our liver transplant program at The Methodist Hospital continued to expand, performing life-saving liver transplants to the sickest individuals. Unfortunately, due to the complex nature of end-stage liver disease and cirrhosis, we are all sobered by the reality that some patients became too ill to transplant, or a suitable donor organ was unavailable at the time it was needed most.

During this past year, we spoke with many of our patients regarding upcoming hepatitis C research studies. We have several studies that are going to begin soon after New Years. We have not forgotten about you, and you have all been entered into our research database. The studies will include several different classes of patients, including: those naïve to hepatitis C therapy (never treated before), those treated with no response to therapy (null responder), and those with partial treatment response who may have relapsed. Each study is for a specific population of patient, each with its own unique entry criteria specified by the sponsor and the Food and Drug Administration.

For those who are awaiting a research study, kindly communicate with us if there have been any changes in your status. You can call our research office or communicate with Herman Ortiz directly through this link and the form at the bottom of the page.

Later this winter, we plan to expand a satellite clinic in Sugar Land, Texas. We will be holding clinic on the campus of the Methodist Hospital-Sugar Land, conveniently at the intersection of US 59 and Sweetwater Blvd. This will allow easier access to our services for those living in Fort Bend County, and further south along the gulf coast.

We are very optimistic for 2011, and the care we continue to provide to our patients. A patient web portal will be available soon, allowing patients access to their medical records, and greater ease of communication with our staff. Our website, www.texasliver.com, is going through an upgrade that will offer a more interactive environment for visitors to the site. Expanded use of audio and video capability will increase the information shared on the site. The expanded blog will offer patients and visitors the opportunity to share in the discussion regarding health and wellness. Visit the site soon to experience these upgrades. Your feedback is welcomed.

All of us at Liver Specialists of Texas wish you the best of health and happiness for 2011.

Joseph S. Galati, M.D. and staff

24-Dec-10 10:00 AM

I Was Just Diagnosed with Hepatitis C: What Can I Expect?

Dr. Joseph Galati Galati - noemail@texasliver.com — Sat, 31 Jul 2010 18:00:00 GMT

Part I: What do I do now that I have been diagnosed with chronic hepatitis C.

31-Jul-10 1:00 PM

Liver Specialists of Texas Newsletter Volume 9 No 5

Dr. Joseph Galati Galati - noemail@texasliver.com — Wed, 12 May 2010 04:00:00 GMT

Welcome to the Liver Specialists of Texas newsletter of upcoming events, articles, jobs and more from our membership. Keep up to date with the latest in liver disease news, as well as general health and wellness information. We all look forward to feed back, and topics in the future you would like to learn about.

March was Colon Cancer Awareness Month: Podcast

March was colon cancer awareness month. Listen to Dr. Galati's podcast here. Among cancers that affect both men and women, colorectal cancer—cancer of the colon or rectum—is the second leading cause of cancer-related deaths in the United States. Colorectal cancer also is one of the most commonly diagnosed cancers in the United States. The risk of developing colorectal cancer increases with advancing age. More than 90% of cases occur in people aged 50 or older. Colorectal cancer... [More Info]

Too Much Dietary Salt: A Conversation with a Nutrition Expert

An interview from Your Health First, this is an informative discussion with a dietitian, explaining the problems of too much salt in the American diet.

Salt Overload: Podcast

More on the excess salt (aka sodium) we all consume.

Alcohol Awareness Month

For addition health and wellness information, tune into Talk Radio 740 KTRH every Sunday evening at 7:00 p.m. for Your Health First, hosted by Dr. Galati. Go to www.yourhealthfirst.com for more details and program information.

11-May-10 11:00 PM